Twist Bioscience Corp (TWST)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Twist Bioscience Corp-Aktie (TWST)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.74% 103.70	99.01	96.06	92.79	88.71
Cost Of Revenue	3.23% 49.73	48.17	44.76	46.77	45.87
Gross Profit	6.17% 53.97	50.84	51.30	46.03	42.84
Operating Expenses	7.55% 86.87	80.77	81.42	87.59	77.48
Benefits Costs and Expenses	6.40% 133.95	125.89	75.48	131.95	120.21
Costs And Expenses	5.94% 136.60	128.94	126.18	134.35	123.36
Operating Income/Loss	9.91% -32.90	-29.93	-30.12	-41.56	-34.64
Income/Loss From Continuing Operations Before Tax	12.55% -30.25	-26.88	20.58	-39.15	-31.50
Income Tax Expense/Benefit	1.56% 0.253	0.257	0.191	0.175	0.097
Income/Loss From Continuing Operations After Tax	12.41% -30.51	-27.14	20.39	-39.33	-31.59
Net Income/Loss	12.41% -30.51	-27.14	20.39	-39.33	-31.59
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	29,265% 61.08	0.208	59.99	59.65	59.16
Diluted Average Shares	29,265% 61.08	0.208	61.16	59.65	59.16
Basic Earnings Per Share	11.11% -0.50	-0.45	0.34	-0.66	-0.53
Diluted Earnings Per Share	11.11% -0.50	-0.45	0.33	-0.66	-0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

$263.80

0.34%

DGX

$199.70

0.59%

MTD

$1,173.74

0.49%

NTRA

$187.85

1.29%

IQV

$164.72

1.10%

WAT

$286.57

1.15%